TY - JOUR
T1 - A case of Turcot's syndrome type 1 with loss of immunoexpression of MSH6 in colon cancer and liver metastasis due to secondary somatic mutation in coding mononucleotide (C)8 tract
T2 - A case report
AU - Akabane, Shintaro
AU - Hinoi, Takao
AU - Akagi, Kiwamu
AU - Yamamoto, Hideki
AU - Sada, Haruki
AU - Shimizu, Yosuke
AU - Shimizu, Wataru
AU - Sudo, Takeshi
AU - Onoe, Takashi
AU - Ishiyama, Kohei
AU - Suzuki, Takahisa
AU - Tazawa, Hirofumi
AU - Hadano, Naoto
AU - Misumi, Toshihiro
AU - Kojima, Masato
AU - Kubota, Haruna
AU - Taniyama, Daiki
AU - Kuraoka, Kazuya
AU - Tashiro, Hirotaka
AU - Hinoi, Takao
N1 - Funding Information:
The study design, genetic analysis of this research was supported by Japan Agency for Medical Research and Development (AMED) under Grant Number JP18kk0205004 in terms of the collection, analysis, and interpretation of data.
Publisher Copyright:
© 2020 The Author(s).
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Background: Lynch syndrome (LS), which is known as a hereditary cancer syndrome, is distinguished by microsatellite instability, represented by the altered number of repetitive sequences in the coding and/or non-coding region. Immunohistochemical staining (IHC) of DNA mismatch repair (MMR) proteins (e.g., MLH1, MSH2, MSH6, and PMS2) has been recognized as an useful technique for screening of LS. Previous study has shown that the assessment of IHC, however, requires specific caution due to variable staining patterns even without germline mutations in MMR genes. Case presentation: A 48-year-old man, who had been treated for anaplastic astrocytoma, was referred to our department for the precise examination of progressing anemia. Whole-body examination revealed two advanced carcinomas in descending colon and stomach. A hypo-vascular mass lesion was detected in liver as well. Pathological diagnosis (on surgical specimens) was poorly differentiated adenocarcinoma in descending colon, moderately differentiated tubular adenocarcinoma in stomach, and liver metastasis, which is possibly from colon. It was suspected that this case would be Turcot's syndrome-type-1 due to its specific family history having two cases of colon cancer within the second relatives. Pathogenic frameshift mutations in codon 618 of MLH1 gene was identified. Immunohistochemical analyses (IHC) demonstrated complete loss of MLH1 immuno-expression as well as of PMS2 except for those in brain tumor. Although frameshift mutation was not found in MSH6 gene, histological expression of MSH6 was patchy in primary colon carcinoma and was completely lost in the metastatic site in liver. MSH6 expression in gastric carcinoma, a coincidental cancer in this case, was intact. An abnormal (C)8 region was identified by the cloned PCR of colon and liver tumors but not from gastric cancer. Frameshift mutation in a (C)8 tract in exon 5 of the MSH6 gene was also detected in liver metastasis. Conclusion: This case supports a plausible mechanism, proposed by a previous literature, for the reduced expression of MSH6 in a somatic mutation manner, which might preferentially happen in colon cancer rather than in stomach carcinoma in MLH1/PMS2-deficient type of Turcot's syndrome type 1.
AB - Background: Lynch syndrome (LS), which is known as a hereditary cancer syndrome, is distinguished by microsatellite instability, represented by the altered number of repetitive sequences in the coding and/or non-coding region. Immunohistochemical staining (IHC) of DNA mismatch repair (MMR) proteins (e.g., MLH1, MSH2, MSH6, and PMS2) has been recognized as an useful technique for screening of LS. Previous study has shown that the assessment of IHC, however, requires specific caution due to variable staining patterns even without germline mutations in MMR genes. Case presentation: A 48-year-old man, who had been treated for anaplastic astrocytoma, was referred to our department for the precise examination of progressing anemia. Whole-body examination revealed two advanced carcinomas in descending colon and stomach. A hypo-vascular mass lesion was detected in liver as well. Pathological diagnosis (on surgical specimens) was poorly differentiated adenocarcinoma in descending colon, moderately differentiated tubular adenocarcinoma in stomach, and liver metastasis, which is possibly from colon. It was suspected that this case would be Turcot's syndrome-type-1 due to its specific family history having two cases of colon cancer within the second relatives. Pathogenic frameshift mutations in codon 618 of MLH1 gene was identified. Immunohistochemical analyses (IHC) demonstrated complete loss of MLH1 immuno-expression as well as of PMS2 except for those in brain tumor. Although frameshift mutation was not found in MSH6 gene, histological expression of MSH6 was patchy in primary colon carcinoma and was completely lost in the metastatic site in liver. MSH6 expression in gastric carcinoma, a coincidental cancer in this case, was intact. An abnormal (C)8 region was identified by the cloned PCR of colon and liver tumors but not from gastric cancer. Frameshift mutation in a (C)8 tract in exon 5 of the MSH6 gene was also detected in liver metastasis. Conclusion: This case supports a plausible mechanism, proposed by a previous literature, for the reduced expression of MSH6 in a somatic mutation manner, which might preferentially happen in colon cancer rather than in stomach carcinoma in MLH1/PMS2-deficient type of Turcot's syndrome type 1.
KW - Lynch syndrome
KW - Microsatellite instability
KW - Mismatch repair gene
KW - Somatic mutation
KW - Turcot's syndrome type 1
UR - http://www.scopus.com/inward/record.url?scp=85087472996&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087472996&partnerID=8YFLogxK
U2 - 10.1186/s12881-020-01079-x
DO - 10.1186/s12881-020-01079-x
M3 - Article
C2 - 32611331
AN - SCOPUS:85087472996
SN - 1471-2350
VL - 21
JO - BMC Medical Genetics
JF - BMC Medical Genetics
IS - 1
M1 - 141
ER -
